Cumberland Pharmaceuticals
Miranda Callahan is an experienced professional in the fields of medical information and pharmacovigilance, currently serving as a Medical Information and Pharmacovigilance Specialist at Cumberland Pharmaceuticals since July 2020. Prior roles include Clinical Trials Assistant at ICON plc, where assistance was provided in managing multinational CNS and Oncology clinical trials. Miranda gained research experience as a Graduate Student Researcher in Medicinal Chemistry at the University of Michigan, focusing on molecular dynamics simulations and drug design. Additional experience includes tutoring and conducting laboratory work during undergraduate studies at The University of the South, and roles in pharmacy and environmental education. Miranda holds a Bachelor of Science in Chemistry and Mathematics from The University of the South and completed graduate studies in Medicinal Chemistry at the University of Michigan.
Cumberland Pharmaceuticals
2 followers
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops and commercializes branded prescription products designed to improve quality of care and address unmet medical needs. With a focus on underserved niche markets, including hospital acute care and gastroenterology, they deliver products that serve patients in the U.S. market. Cumberland also makes its products available to patients internationally through select strategic partnerships. They own the worldwide rights to all their brands. While Cumberland’s commercial capabilities are focused on the U.S. market, their business development team is actively pursuing opportunities to make their brands available to patients in markets around the globe. Their primary mission is to improve upon patient care with products that offer clear advantages over existing treatments. They also strive to deliver solutions that may help reduce costs for healthcare providers and, ultimately, patients.